Search
for
Sort by
Research 661–690 of 1000+
- Correlation of skin-related quality of life with anxiety and depression in chronic dermatoses: A cross-sectional study
- Cationic Ionic Liquid-Liposome Nanoplatform for Transdermal asiRNA Delivery: A Unified Therapy for Androgen-Dependent Dermatoses
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation
- Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
- P‐46 A placebo‐controlled, double‐blinded study of recombinant IFNγ in dogs with atopic dermatitis
- A Rare Case of Orthokeratotic Hyperkeratosis in a Kid Induced by Malassezial Dermatitis
- 713 Fisetin promotes differentiation, inhibits proliferative and inflammatory responses in cultured human cells and alleviates psoriasiform dermatitis in mice
- Lichen Planopilaris and Low-Level Light Therapy: Four Case Reports and Review of the Literature About Low-Level Light Therapy and Lichenoid Dermatosis
- Proliferative, lymphocytic, infundibular mural folliculitis and dermatitis with prominent follicular apoptosis and parakeratotic casts in four Labrador retrievers: preliminary description and response to therapy
- RETRACTED: A two‐sample Mendelian randomization study of mutual relations of six types of diets in atopic dermatitis
- 089 Single-cell RNA sequencing defines molecular similarities between patch/plaque-stage mycosis fungoides and atopic dermatitis under dupilumab
- 42008 Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
- 44180 Influence of Baseline Disease Severity Defined by Investigator’s Global Assessment on Abrocitinib Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study
- Skin manifestations of celiac disease
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Bariatric Surgery and Its Effects on the Skin and Skin Diseases
- Zinc deficiency in female rabbits
- Hair Loss in Autoimmune Cutaneous Bullous Disorders
- Anaemia and skin disease
- Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- The Dermatologic Care Needs of a Rural Community in South Florida
- Erosive Lichen Sclerosus—A Clinicopathologic Subtype
- Somatization in the dermatology patient: Some sociocultural perspectives
- Skin changes in pediatric transplant patients
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases